Sivelestat Sodium Hydrate Treatment for refractory Kawasaki Disease Patients

Additional IVIG combined with SSH as a second‐line therapy for KD patients who were refractory to initial IVIG therapy was safe and well tolerated and could be a promising option for severe KD patients